PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)

Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine. Discussions related to efforts to address smoking rates in certain populations where there has not been a meaningful decline. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.

Discussions related to potential tariffs on imported products. Discussions related to non-tariff barriers to trade and related foreign trade issues. Discussions related to foreign environmental certification.

Discussions related to Veterans and health related issues.

H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; provisions related to reform of the Food and Drug Administration S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; provisions related to reform of the Food and Drug Administration

Discussions related to U.S. policy guidance provided to executive branch personnel regarding foreign government engagements. Discussions related to foreign contractual matters.

Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.

Discussions related to tobacco harm reduction on military installations. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine.

Discussions related to the federal excise tax on ethanol and its application to manufacturing of tobacco products.